# Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)

> **NCT06753838** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 100 (estimated)

## Conditions studied

- Hemostasis

## Interventions

- **BIOLOGICAL:** Sampling of 3 additional BAPA tubes

## Key facts

- **NCT ID:** NCT06753838
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06753838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06753838, "Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06753838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*